Review of Early Signs of Breast Implant Infection.

Aesthetic plastic surgery 2022 Vol.46(5) p. 2152-2158

Zhang R, Singh D, Parsa FD

관련 도메인

Abstract

[BACKGROUND] Breast implant infection remains a problem despite various prevention methods. Common pathogens such as staphylococcus aureus typically present acutely with fever, erythema, swelling, and pain. However, with the increasing occurrence of mycobacterial infections, associated early signs and symptoms are typically absent, making early detection difficult.

[METHOD] A retrospective chart review of patients who underwent esthetic breast augmentation by senior surgeon FDP in an outpatient surgical facility from 1992 to 2021 was conducted. Cases of infections and related information including infection onset, presenting signs and symptoms, and culture results were recorded. Presentation differences between infections caused by common pathogens and mycobacteria were compared.

[RESULTS] A total of nine infections were reported in 365 patients. Seven cases were due to common pathogens: staphylococcus aureus, pseudomonas aeruginosa, methicillin-resistant staphylococcus aureus (MRSA), and staphylococcus epidermidis. Fever, erythema was presented within an average of 10 days after surgery. Two cases were due to mycobacterium chelonae (non-tuberculous mycobacterium) infection. In the latter, the earliest signs and symptoms consisted of mild pain and swelling in the absence of fever and erythema, which began on average of 54 days after the operation.

[CONCLUSION] Common breast implant infection pathogens usually present early with fever and erythema. However, our study found that non-tuberculous mycobacteria infections occur much later and fever and erythema are typically absent. The purpose of this study is to increase the awareness of clinicians with this rare but rapidly increasing variety of infections and to advise the operating surgeon to include mycobacteria infections in the differential diagnosis.

[LEVEL OF EVIDENCE IV] This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
합병증 infection 감염 dict 5
해부 breast 유방 dict 4
시술 breast augmentation 유방성형술 dict 1
합병증 erythema scispacy 1
약물 FDP C0060663
formycin diphosphate
scispacy 1
약물 mycobacterium chelonae C0085441
Mycobacterium chelonae
scispacy 1
약물 [BACKGROUND] Breast implant scispacy 1
약물 [RESULTS] A scispacy 1
질환 Breast Implant Infection C0405488
Infection of breast implant
scispacy 1
질환 fever C0015967
Fever
scispacy 1
질환 erythema C0041834
Erythema
scispacy 1
질환 swelling C0013604
Edema
scispacy 1
질환 pain C0030193
Pain
scispacy 1
질환 mycobacterial infections C0026918
Mycobacterium Infections
scispacy 1
질환 infections C0851162
Infections of musculoskeletal system
scispacy 1
질환 aeruginosa C0033809
Pseudomonas aeruginosa
scispacy 1
질환 methicillin-resistant staphylococcus aureus C0343401
MRSA - Methicillin resistant Staphylococcus aureus infection
scispacy 1
질환 non-tuberculous mycobacterium C1265234
Nontuberculous Mycobacteria
scispacy 1
질환 non-tuberculous mycobacteria infections scispacy 1
질환 Breast Implant scispacy 1
기타 patients scispacy 1
기타 FDP scispacy 1
기타 methicillin-resistant staphylococcus aureus scispacy 1
기타 staphylococcus epidermidis scispacy 1

MeSH Terms

Humans; Breast Implants; Retrospective Studies; Methicillin-Resistant Staphylococcus aureus; Mammaplasty; Staphylococcus aureus; Pain; Breast Implantation; Treatment Outcome

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문